Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share (APVO) Institutional Ownership

Q: What is CUSIP 03835L504?

CUSIP 03835L504 is the security identifier used in SEC filing datasets for APVO - Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share.

Q: Who owns APVO - Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CUSIP: 03835L504

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Symbol: APVO on Nasdaq
Shares outstanding: 3,295,607
Price per share: $0.61
All holders as of 31 Dec 2025: Q4 2025
Total 13F shares: 0
Total reported value: $0
Share change: -493,997
Value change: -$717,121
Number of holders: 0

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 03835L504?
CUSIP 03835L504 identifies APVO - Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 03835L504:

Q4 2025 (0 holders) Q3 2025 (12 holders) Q2 2025 (6 holders)

Significant Owners of Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share (APVO) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
YA II PN, Ltd.	10%		$1,663,965		357,842		YA II PN, Ltd.	16 Jun 2025
CVI Investments, Inc.	9.9%		$1,073,526		357,842		CVI Investments, Inc.	30 Jun 2025
L1 Capital Global Opportunities Master Fund, Ltd.	5%	-50%	$492,900	-$362,100	164,300	-42%	L1 Capital Global Opportunities Master Fund, Ltd.	14 Aug 2025
BANK OF AMERICA CORP /DE/	0%	-100%	$125	-$715,879	86	-100%	BANK OF AMERICA CORP /DE/	31 Oct 2025

As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share (APVO). This represents 0% of the company’s total 3,295,607 outstanding shares.

Institutional Holders of Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share (APVO) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Price (Median)	Investors
2025 Q4	0	$0	-$717,121	$0.61	0
2025 Q3	493,997	$717,121	+$709,654	$1.45	12
2025 Q2	5,035	$15,356	+$15,356	$3.02	6